CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Neuroscience Startups (947)
Cognetix is a biopharmaceutical company that is developing peptide therapeutics for the treatment of epilepsy, pain and anesthesia. The company's research and development efforts are focused on conopeptides which are peptides derived from the venom o...Show all
Company (Alive / Active)
Phone: 801-581-0400
421 Wakara Way
Suite 201
Salt Lake City, 84108
Utah, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Cognetix | $17M | Jul 6, 2001 |
| See all 16 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Alpha-conotoxin peptides | Jun 06, 2013 | May 27, 2014 | Patent |
| �-conotoxin peptides | Oct 09, 2007 | Feb 23, 2010 | Patent |
